View source for Top 25 Quotes On Xarelto Lawsuit

Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical organizations, which includes the makers of Xarelto, have a duty to make sure that their drugs are reasonably protected for use - and failure to complete so could be grounds for compensation. Our lawyers are operating challenging to have those hurt by the drug the compensation they're entitled to.<br><br>Although bleeding can be a typical complication connected with anticoagulants, it has been alleged that Xarelto is much more dangerous than traditional blood thinners because no antidote exists to reverse its blood-thinning effects. This indicates that, within the event of an emergency, sufferers may possibly be at risk for irreversible bleeding difficulties, such as life-threatening internal and gastrointestinal hemorrhaging.<br><br>In case you or a loved one suffered a significant bleeding event right after taking Xarelto, you may have legal recourse. For far more details, speak to us these days to possess your case reviewed, free of charge.<br>Compensation Possibilities<br><br>xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for past and future medical bills, lost wages, discomfort and suffering and, in situations of death, funeral costs. In addition, they may be looking for punitive damages, that are generally awarded to punish the defendant and deter other companies from acting similarly.<br>Why Are Lawsuits Being Filed?<br><br>Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs within the lawsuits allege critical and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.<br><br>In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:<br><br>The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.<br>The makers of the drug continue to market Xarelto as a secure anticoagulant option.<br>Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user within the [https://www.Gov.uk/search?q=occasion occasion] of a bleeding complication.<br>Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.<br>Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.<br><br>Visit this page for much more details on the alleged health risks of Xarelto.<br>Multidistrict Litigation Trial Dates Set<br><br>The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled  [http://www.rejangskin.com/qna/2357/theres-big-money-in-xarelto-lawsuit www.rejangskin.com] for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.